Sandra Rajme‐López

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +3

Clinical and Epidemiological Characteristics of Patients Diagnosed with COVID-19 in a Tertiary Care Center in Mexico City: A Prospective Cohort Study

Edgar Ortíz‐Brizuela, Marco Villanueva-Reza, María Fernanda González-Lara et al. · Revista de investigaci�n Cl�nica · 2020 · 107 citations

Medicine, Infectious Diseases, Internal Medicine +9

Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic

Bernardo Alfonso Martínez-Guerra, María Fernanda González-Lara, Nereyda A. de-León-Cividanes et al. · Antibiotics · 2021 · 57 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients

Eric Ochoa‐Hein, Sandra Rajme‐López, Juan Carlos Rodríguez‐Aldama et al. · American Journal of Infection Control · 2020 · 46 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17

Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study

Sandra Rajme‐López, Bernardo Alfonso Martínez-Guerra, Jessica Zalapa‐Soto et al. · Open Forum Infectious Diseases · 2022 · 43 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13